<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using a porphyritic microsensor, we measured the cortical NO concentration within ischemic tissue during 2 h of middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion and 1 h of reperfusion in the rat (n = 36) </plain></SENT>
<SENT sid="1" pm="."><plain>Local cerebral blood flow was simultaneously measured by laser Doppler flowmetry to verify <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion and reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Baseline concentration of NO was &lt; 10(-8) M </plain></SENT>
<SENT sid="3" pm="."><plain>The maximum concentrations of NO during <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion and reperfusion were, respectively, 1.47 +/- 0.45 microM and 0.54 +/- 0.24 microM </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of N-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>), an inhibitor of NO synthase, prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, significantly (p &lt; 0.05) reduced NO release to 0.04 +/- 0.02 microM during <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion and completely inhibited NO release during 1 h of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> 30 min after administration of L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> restored NO release (3.45 +/- 1.14 microM) during <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion; however, administration of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> did not overcome the effect of L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> on mean arterial blood pressure </plain></SENT>
<SENT sid="6" pm="."><plain>Our data indicate that NO is released in the brain after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and NO levels can be modulated by administration of NO substrate and NO <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
</text></document>